These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 34816459)
61. MYO5B, STX3, and STXBP2 mutations reveal a common disease mechanism that unifies a subset of congenital diarrheal disorders: A mutation update. Dhekne HS; Pylypenko O; Overeem AW; Zibouche M; Ferreira RJ; van der Velde KJ; Rings EHHM; Posovszky C; van der Sluijs P; Swertz MA; Houdusse A; van IJzendoorn SCD Hum Mutat; 2018 Mar; 39(3):333-344. PubMed ID: 29266534 [TBL] [Abstract][Full Text] [Related]
62. Approach to Congenital Diarrhea and Enteropathies (CODEs). Kijmassuwan T; Balouch F Indian J Pediatr; 2024 Jun; 91(6):598-605. PubMed ID: 38105403 [TBL] [Abstract][Full Text] [Related]
63. Genetic Enteropathies Linked to Epithelial Structural Abnormalities and Enteroendocrine Deficiency: A Systematic Review. Caralli M; Roman C; Coste ME; Roquelaure B; Buffat C; Bourgeois P; Badens C; Fabre A J Pediatr Gastroenterol Nutr; 2021 Jun; 72(6):826-832. PubMed ID: 33976085 [TBL] [Abstract][Full Text] [Related]
64. Trafficking Ion Transporters to the Apical Membrane of Polarized Intestinal Enterocytes. Engevik AC; Goldenring JR Cold Spring Harb Perspect Biol; 2018 Jan; 10(1):. PubMed ID: 28264818 [TBL] [Abstract][Full Text] [Related]
65. Mutations in Myosin 5B in Children With Early-onset Cholestasis. Cockar I; Foskett P; Strautnieks S; Clinch Y; Fustok J; Rahman O; Sutton H; Mtegha M; Fessatou S; Kontaki E; Papaevangelou V; Deheragoda M; Thompson RJ; Grammatikopoulos T J Pediatr Gastroenterol Nutr; 2020 Aug; 71(2):184-188. PubMed ID: 32304554 [TBL] [Abstract][Full Text] [Related]
66. MYO5B gene mutations may promote the occurrence of very early onset inflammatory bowel disease: a case report. Lou Y; Lv Y; Yu J; Gu W; Jiang M; Chen J BMC Med Genomics; 2024 Jul; 17(1):187. PubMed ID: 39014344 [TBL] [Abstract][Full Text] [Related]
67. Villin immunohistochemistry is a reliable method for diagnosing microvillus inclusion disease. Shillingford NM; Calicchio ML; Teot LA; Boyd T; Kurek KC; Goldsmith JD; Bousvaros A; Perez-Atayde AR; Kozakewich HP Am J Surg Pathol; 2015 Feb; 39(2):245-50. PubMed ID: 25517957 [TBL] [Abstract][Full Text] [Related]
68. Microvillus inclusion disease: a subtotal enterectomy as a bridge to transplantation. van Hoeve K; Hoffman I; Fusaro F; Pirenne J; Vander Auwera A; Dieltjens AM; De Hertogh G; Monbaliu D; Miserez M Acta Chir Belg; 2016 Dec; 116(6):333-339. PubMed ID: 27477384 [TBL] [Abstract][Full Text] [Related]
70. Compound Heterozygous Myosin 5B (Myo5b) Mutation with Early Onset Progressive Cholestasis and No Intestinal Failure. Vij M; Shah V Fetal Pediatr Pathol; 2022 Oct; 41(5):811-817. PubMed ID: 34338607 [No Abstract] [Full Text] [Related]
71. MYO5B Gene Mutations: A Not Negligible Cause of Intrahepatic Cholestasis of Infancy With Normal Gamma-Glutamyl Transferase Phenotype. Matarazzo L; Bianco AM; Athanasakis E; Serveres M; Francalanci P; Cenacchi G; Maggiore G; D'Adamo AP J Pediatr Gastroenterol Nutr; 2022 May; 74(5):e115-e121. PubMed ID: 35129155 [TBL] [Abstract][Full Text] [Related]
72. Toward a cellular model of microvillus inclusion disease. Wilkie AO Hum Mutat; 2010 May; 31(5):v. PubMed ID: 20437611 [No Abstract] [Full Text] [Related]
73. Microvillus Inclusion Disease Variant in an Infant with Intractable Diarrhea. Alsaleem BMR; Ahmed ABM; Fageeh MA Case Rep Gastroenterol; 2017; 11(3):647-651. PubMed ID: 29282386 [TBL] [Abstract][Full Text] [Related]
74. Dynamic Formation of Microvillus Inclusions During Enterocyte Differentiation in Mosa MH; Nicolle O; Maschalidi S; Sepulveda FE; Bidaud-Meynard A; Menche C; Michels BE; Michaux G; de Saint Basile G; Farin HF Cell Mol Gastroenterol Hepatol; 2018; 6(4):477-493.e1. PubMed ID: 30364784 [TBL] [Abstract][Full Text] [Related]